![Adipogen/b-AP15 [DUB Inhibitor] Solution/AG-CS1-0102-M010/10 mg](https://www.ebiomall.cn/images/adipogen/ag-cs1-0102_b-ap15_solution.png)
Adipogen/b-AP15 [DUB Inhibitor] Solution/AG-CS1-0102-M010/10 mg
商品编号:
AG-CS1-0102-M010
品牌:
Adipogen Inc
市场价:
¥12180.00
美元价:
7308.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Product Details | |
---|---|
Synonyms | VLX1500; NSC 687852 |
Product Type | Chemical |
Properties | |
Formula | C22H17N3O6 |
MW | 419.4 |
CAS | 1009817-63-3 |
Purity Chemicals | ≥98% (HPLC) |
Appearance | Liquid. |
Formulation | 10mM stock solution in DMSO. |
Biological Activity | Inhibits purified 19S deubiquitinase activity using Ub-AMC as substrate (in vitro IC50=2.1μM). Decreases HCT-116 cell viability at 72 hours (EC50=0.4μM). |
Identity | Determined by 1H-NMR. |
Declaration | Manufactured by Boston Biochem |
Other Product Data | Note: May hydrolyze slowly in aqueous buffers. |
InChi Key | GFARQYQBWJLZMW-JYFOCSDGSA-N |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Avoid freeze/thaw cycles. |
Use/Stability | Stable for at least 6 months after receipt when stored at -20°C. |
Documents | |
MSDS |
![]() |
Product Specification Sheet | |
Datasheet |
![]() |
- Potent, reversible and cell-permeable inhibitor of the 19S deubiquitinases (DUBs) ubiquitin-specific-processing protease 14 (USP14) and ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCHL5).
- Inhibitor of the 20S proteasome.
- Anti-tumor compound.
Product References
- Inhibition of proteasome deubiquitinating activity as a new cancer therapy: P. D'Arcy, et al.; Nat. Med. 17, 1636 (2011)
- A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance: Z. Tian, et al.; Blood 123, 706 (2014)
- The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death: X. Wang, et al.; Mol. Pharmacol. 85, 932 (2014)
- Inhibitory effect of b-AP15 on the 20S proteasome: L. Huang, et al.; Biomolecules 4, 931 (2014)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们